Milestone Pharmaceuticals Inc. held its annual meeting of shareholders on June 10, 2025. Shareholders approved the amendment of the 2019 Equity Incentive Plan, which included removing the evergreen provision and increasing the number of authorized shares by 4,000,000. The election of directors was also approved, with all nominees elected to the board. Additionally, the selection of PricewaterhouseCoopers LLP as the company's auditor was ratified.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.